株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のナノバイオテクノロジー市場 2018年~2022年

Global Nanobiotechnology Market 2018-2022

発行 TechNavio (Infiniti Research Ltd.) 商品コード 657666
出版日 ページ情報 英文 113 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
世界のナノバイオテクノロジー市場 2018年~2022年 Global Nanobiotechnology Market 2018-2022
出版日: 2018年06月27日 ページ情報: 英文 113 Pages
概要

ナノバイオテクノロジーについて

ナノバイオテクノロジーは、ナノテクノロジーのツールを応用して、生物学的現象を研究する分野です。

Technavioのアナリストは、2018年から2022年にかけて、世界のナノバイオテクノロジー市場が8.51%のCAGRで成長すると予測しています。

当レポートでは、世界のナノバイオテクノロジー市場について調査し、市場の概要、市場動向、エンドユーザー・地域別の市場規模の推移と予測、成長要因および課題の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 調査方法

第4章 市場状況

  • 市場のエコシステム
  • 市場特性
  • 市場セグメンテーション分析

第5章 市場規模

  • 市場の定義
  • 市場規模
  • 市場規模の予測

第6章 ファイブフォース分析

  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
  • 市場状況

第7章 市場セグメンテーション:エンドユーザー別

  • 市場区分:エンドユーザー別
  • 市場比較:エンドユーザー別
  • 製薬・バイオテクノロジー
  • 医療機器
  • その他
  • 市場機会:エンドユーザー別

第8章 顧客情勢

第9章 地域情勢

  • 市場区分:地域別
  • 市場比較:地域別
  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋
  • 市場機会

第10章 意思決定の枠組み

第11章 成長要因と課題

  • 市場の成長要因
  • 市場の課題

第12章 市場動向

  • 幹細胞治療におけるナノバイオテクノロジーの需要増大
  • 慢性疾患の高い罹患率
  • 金ナノ粒子の利用の増加

第13章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第14章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Ablynx
  • CELGENE
  • Merck KGaA
  • NanoBiotech Pharma
  • Thermo Fisher Scientific

第15章 付録

  • 略語のリスト
図表
  • Exhibit 01: Parent market
  • Exhibit 02: Global nanotechnology market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global nanobiotechnology market- Market size and forecast 2017-2022 ($ bn)
  • Exhibit 09: Global nanobiotechnology market- Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global nanobiotechnology market by end-user - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Pharmaceutical and biotechnology industry - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 21: Pharmaceutical and biotechnology industry - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Medical devices- Market size and forecast 2017-2022 ($ bn)
  • Exhibit 23: Medical devices- Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Others - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 25: Others - Year-over-year growth 2018-2022 (%)
  • Exhibit 26: Market opportunity by end-user
  • Exhibit 27: Customer landscape
  • Exhibit 28: Global nanobiotechnology market - Market share by geography 2017-2022 (%)
  • Exhibit 29: Regional comparison
  • Exhibit 30: Americas - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 31: Americas - Year over year growth 2018-2022 (%)
  • Exhibit 32: Top three countries in Americas
  • Exhibit 33: EMEA - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 34: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 35: Top three countries in EMEA
  • Exhibit 36: APAC - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 37: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 38: Top 3 countries in APAC
  • Exhibit 39: Market opportunity
  • Exhibit 40: Nanobiotechnology-based products under clinical trials
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Ablynx overview
  • Exhibit 47: Ablynx - Business segments
  • Exhibit 48: Ablynx - Organizational developments
  • Exhibit 49: Ablynx - Geographic focus
  • Exhibit 50: Ablynx - Segment focus
  • Exhibit 51: Ablynx - Key offerings
  • Exhibit 52: CELGENE overview
  • Exhibit 53: CELGENE - Business segments
  • Exhibit 54: CELGENE - Organizational developments
  • Exhibit 55: CELGENE - Geographic focus
  • Exhibit 56: CELGENE - Segment focus
  • Exhibit 57: CELGENE - Key offerings
  • Exhibit 58: Merck KGaA overview
  • Exhibit 59: Merck KGaA - Business segments
  • Exhibit 60: Merck KGaA - Organizational developments
  • Exhibit 61: Merck KGaA - Geographic focus
  • Exhibit 62: Merck KGaA - Segment focus
  • Exhibit 63: Merck KGaA - Key offerings
  • Exhibit 64: NanoBiotech Pharma overview
  • Exhibit 65: NanoBiotech Pharma - Business segments
  • Exhibit 66: NanoBiotech Pharma - Organizational developments
  • Exhibit 67: NanoBiotech Pharma - Geographic focus
  • Exhibit 68: NanoBiotech pharma - Key offerings
  • Exhibit 69: Thermo Fisher Scientific overview
  • Exhibit 70: Thermo Fisher Scientific - Business segments
  • Exhibit 71: Thermo Fisher Scientific - Organizational developments
  • Exhibit 72: Thermo Fisher Scientific - Geographic focus
  • Exhibit 73: Thermo Fisher Scientific - Segment focus
  • Exhibit 74: Thermo Fisher Scientific - Key offerings
目次
Product Code: IRTNTR22571

About Nanobiotechnology

Nanobiotechnology is a discipline in which tools from nanobiotechnology are developed and applied to study biological phenomena.

Technavio's analysts forecast the Global Nanobiotechnology Market to grow at a CAGR of 8.51% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global nanobiotechnology market. To calculate the market size, the report considers the revenue generated from the sales of nanobiotechnology products such as nanoparticles, bionanomaterials, and liposomes.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Nanobiotechnology Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Ablynx
  • CELGENE
  • Merck KGaA
  • NanoBiotech Pharma
  • Thermo Fisher Scientific

Market driver

  • Increasing focus on nanotechnology research
  • For a full, detailed list, view our report

Market challenge

  • Lack of trained professionals
  • For a full, detailed list, view our report

Market trend

  • High prevalence of chronic diseases
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY END-USER

  • Segmentation by end-user
  • Comparison by end-user
  • Pharmaceutical and biotechnology industry- Market size and forecast 2017-2022
  • Medical devices - Market size and forecast 2017-2022
  • Others - Market size and forecast 2017-2022
  • Market opportunity by end-user

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increasing demand for nanobiotechnology in stem cell therapy
  • High prevalence of chronic diseases
  • Growing use of gold nanoparticles

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Ablynx
  • CELGENE
  • Merck KGaA
  • NanoBiotech Pharma
  • Thermo Fisher Scientific

PART 15: APPENDIX

  • List of abbreviations
Back to Top